financetom
Business
financetom
/
Business
/
Somnigroup International Q3 Adjusted Earnings, Net Sales Rise; 2025 Adjusted EPS Outlook Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Somnigroup International Q3 Adjusted Earnings, Net Sales Rise; 2025 Adjusted EPS Outlook Raised
Nov 6, 2025 4:40 AM

07:11 AM EST, 11/06/2025 (MT Newswires) -- Somnigroup International ( SGI ) reported Q3 adjusted earnings Thursday of $0.95 per diluted share, up from $0.82 a year earlier.

Analysts polled by FactSet expected $0.86.

Net sales for the quarter ended Sept. 30 were $2.12 billion, up from $1.30 billion a year earlier.

Analysts surveyed by FactSet expected $2.06 billion.

The company said it now expects 2025 adjusted EPS in the range of $2.60 to $2.75, up from its prior range of $2.40 to $2.70. Analysts polled by FactSet expect $2.57.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Blank Check Company Cohen Circle Aqusition Corp. II Files For IPO Of $220 Mln - SEC Filing
BRIEF-Blank Check Company Cohen Circle Aqusition Corp. II Files For IPO Of $220 Mln - SEC Filing
May 26, 2025
May 23 (Reuters) - * BLANK CHECK COMPANY COHEN CIRCLE AQUSITION CORP. II FILES FOR IPO OF $220 MILLION - SEC FILING * COHEN CIRCLE AQUSITION CORP II: CLEAR STREET IS UNDERWRITER TO IPO * COHEN CIRCLE ACQUISITION CORP II: INTENDS TO LIST UNITS ON NASDAQ UNDER THE SYMBOL CCIIU Source text: Further company coverage: [ ] ...
Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication
Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication
May 26, 2025
10:13 AM EDT, 05/23/2025 (MT Newswires) -- The European Medicines Agency's Committee for Medicinal Products for Human Use said Friday it recommended an extension of therapeutic indication for Beigene's ( ONC ) cancer drug Tevimbra. Tevimbra is already authorized in the EU, the committee said, with indications for non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, and oesophageal squamous...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BRIEF-Herc Holdings Extends Tender Offer to Acquire H&E Equipment Services
BRIEF-Herc Holdings Extends Tender Offer to Acquire H&E Equipment Services
May 26, 2025
May 23 (Reuters) - Herc Holdings Inc ( HRI ): * HERC HOLDINGS EXTENDS TENDER OFFER TO ACQUIRE H&E EQUIPMENT SERVICES * HERC HOLDINGS INC ( HRI ) - TENDER OFFER EXTENDED UNTIL MAY 29, 2025 Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved